Strategies to improve anxiety and depression in patients with COPD: a mental health perspective

Tselebis, Athanasios; Pachi, Argyro; Ilias, Ιoannis; Kosmas, Epaminondas; Bratis, Dionisios; Moussas, G.; Tzanakis, Νikolaos

doi:10.2147/ndt.s79354

Cited by 105 publications

(100 citation statements)

References 268 publications

(223 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Currently, the findings of randomised controlled trials pointed out that activity with breathing with 15 min per time, twice a day for 12 weeks improved depression (Cheng, Wang, Chou, & Yeh, 2018) and heart failure patients' anxiety (Teng, Yeh, & Wang, 2018). However, the effects of anxiety and depression are limited for patients with COPD (Tselebis et al, 2016).…”

Section: Backg Rou N Dmentioning

confidence: 99%

“…Chronic obstructive pulmonary disease (COPD) is a treatable but high burden disease that has negative impacts on patients’ bio‐psychological well‐being such as anxiety, depression (Tselebis et al, ), dyspnoea (Chang, Dai, Chien, & Chan, ; Yeh, Chen, Liao, & Liao, ) and quality of life (Blakemore et al, ). Relieving these symptoms and improving quality of life are targeted to manage COPD patients.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Two‐month breathing‐based walking improves anxiety, depression, dyspnoea and quality of life in chronic obstructive pulmonary disease: A randomised controlled study

Lin

Yeh

Lai

et al. 2019

Journal of Clinical Nursing

View full text Add to dashboard Cite

Aims and objectives To examine the effects of the two‐month breathing‐based walking intervention and its follow‐up on anxiety, depression, dyspnoea and quality of life in patients with chronic obstructive pulmonary disease. Background Mind–body‐related exercises improve bio‐psychological symptoms and quality of life in chronic diseases, but these improvements are not proven for chronic obstructive pulmonary disease. Design This was a randomised controlled study and applied the Consolidated Standards of Reporting Trials (CONSORT) statement. Methods Outpatients diagnosed with chronic obstructive pulmonary disease were recruited from a medical centre in Taiwan and randomly assigned to two groups. The walking group (n = 42) received breathing, meditation and walking for two months, and the control group (n = 42) did not. Data from the outcomes of anxiety, depression, dyspnoea and quality of life were collected at baseline and in Month 1, Month 2 and Month 3. Clinical trial registration was done (ClinicalTrials.gov.: NCT03388489). Findings The results showed significant changes in anxiety, depression, dyspnoea and quality of life in the walking group across three months, compared to those in the control group and at baseline. Conclusion This breathing‐based walking intervention is promising to achieve bio‐psychological well‐being for patients with chronic obstructive pulmonary disease. Relevance to clinical practice This breathing‐based walking, as a mind–body exercise, could serve as an evidence‐based nursing care that contributes to improving anxiety, depression, dyspnoea and quality of life in stable chronic obstructive pulmonary disease outpatients. The feasibility and acceptability of the breathing‐based walking were met the requirement of the chronic obstructive pulmonary disease outpatients, which could be considered as home‐based exercise.

show abstract

Section: Backg Rou N Dmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Two‐month breathing‐based walking improves anxiety, depression, dyspnoea and quality of life in chronic obstructive pulmonary disease: A randomised controlled study

Lin

Yeh

Lai

et al. 2019

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…In fact, one of the primary reasons for individuals with pulmonary disease to undergo pulmonary rehabilitation is alleviation of anxiety. One study reported rates of depression at 37%‐71%, and rates of anxiety at 50%‐75% in patients with severe COPD disease [82]. Anxiety in patients with CLD is intimately linked with patients' fears of acute dyspnea attacks with a sense of suffocation and fear of death [82].…”

Section: Special Considerations In Lt Recipients In the Acute Rehabilmentioning

confidence: 99%

“…One study reported rates of depression at 37%-71%, and rates of anxiety at 50%-75% in patients with severe COPD disease [82]. Anxiety in patients with CLD is intimately linked with patients' fears of acute dyspnea attacks with a sense of suffocation and fear of death [82]. These comorbid psychological impairments have been implicated to predict increased functional impairment, disability, morbidity, lower QOL, and decreased adherence to treatment [82].…”

Section: Special Considerations In Lt Recipients In the Acute Rehabilmentioning

confidence: 99%

A Review of Lung Transplantation and Its Implications for the Acute Inpatient Rehabilitation Team

Hatt

Kinback

Shah

et al. 2016

PM&R

View full text Add to dashboard Cite

show abstract

“…In a recent meta-analysis, researchers showed that adding psychotherapy to antidepressant medications was twice as effective as compared to antidepressant treatment alone 16 in reducing depressive symptoms. However, evidence regarding combination therapy use in the management of depression in COPD population has been limited 17 .…”

Section: Introductionmentioning

confidence: 99%

Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression

Deb

Sambamoorthi

2016

Current Medical Research and Opinion

View full text Add to dashboard Cite

Objective To estimate rates and the patterns of depression treatment among adults with Chronic Obstructive Pulmonary Disease (COPD) and depression. Methods We used a retrospective, cross-sectional study design, pooling data from 2010 and 2012 Medical Expenditure Panel Survey (MEPS). The study sample consisted of 527 individuals aged 21 years or older, diagnosed with COPD and depression. Depression treatment was grouped into 3 categories based on those who received: 1) neither antidepressant nor psychotherapy; 2) antidepressants only; and 3) psychotherapy combined with antidepressants (combination therapy). We conducted chi-squared tests and multinomial logistic regressions to examine factors (demographic, socio-economic characteristics, healthcare access, health status, and personal health practices) associated with depression treatment among adults with COPD and depression. Key Findings The mean age of the study sample was 55.96 years(SD=13.36). Overall, 18.8% of the sample adults did not report any use of antidepressants or psychotherapy, 58.3% reported antidepressants use only and 23% reported using combination therapy. Females(AOR=1.89, 95% CI= 1.02, 3.55), older adults(>=65 years: AOR=3.69, 95% CI= 1.62, 8.41), adults with fair/poor physical health status(AOR=3.32, 95% CI=1.29, 8.56) and those suffering from anxiety (AOR=1.94, 95% CI= 1.09, 3.46) were more likely to receive antidepressant treatment. Older adults(AOR=2.94, 95% CI=1.05, 8.22), those who were never married(AOR=3.17, 95% CI=1.18, 8.56), suffered from anxiety(AOR=6.01, 95% CI=3.11, 11.61) and current smokers (AOR=2.29, 95% CI= 1.05, 4.98) were more likely to receive combination therapy. Whereas, adults who were uninsured(AOR=0.21, 95% CI= 0.05, 0.86) and did not have physical activity (AOR=0.33, 95% CI= 0.16, 0.67) were less likely to receive combination therapy. Key limitations of our study is that we could not control for the severity of depression or COPD which may have influenced depression treatment. Conclusion Efforts to improve depression care among adults with co-occurring COPD and depression may need to be tailored for different subgroups.

show abstract

Strategies to improve anxiety and depression in patients with COPD: a mental health perspective

Cited by 105 publications

References 268 publications

Two‐month breathing‐based walking improves anxiety, depression, dyspnoea and quality of life in chronic obstructive pulmonary disease: A randomised controlled study

Two‐month breathing‐based walking improves anxiety, depression, dyspnoea and quality of life in chronic obstructive pulmonary disease: A randomised controlled study

A Review of Lung Transplantation and Its Implications for the Acute Inpatient Rehabilitation Team

Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression

Contact Info

Product

Resources

About